Literature DB >> 17287469

Ca2+/calmodulin-dependent protein kinase kinase-alpha regulates skeletal muscle glucose uptake independent of AMP-activated protein kinase and Akt activation.

Carol A Witczak1, Nobuharu Fujii, Michael F Hirshman, Laurie J Goodyear.   

Abstract

Studies in nonmuscle cells have demonstrated that Ca(2+)/calmodulin-dependent protein kinase kinases (CaMKKs) are upstream regulators of AMP-activated protein kinase (AMPK) and Akt. In skeletal muscle, activation of AMPK and Akt has been implicated in the regulation of glucose uptake. The objective of this study was to determine whether CaMKKalpha regulates skeletal muscle glucose uptake, and whether it is dependent on AMPK and/or Akt activation. Expression vectors containing constitutively active CaMKKalpha (caCaMKKalpha) or empty vector were transfected into mouse muscles by in vivo electroporation. After 2 weeks, caCaMKKalpha was robustly expressed and increased CaMKI (Thr(177/180)) phosphorylation, a known CaMKK substrate. In muscles from wild-type mice, caCaMKKalpha increased in vivo [(3)H]-2-deoxyglucose uptake 2.5-fold and AMPKalpha1 and -alpha2 activities 2.5-fold. However, in muscles from AMPKalpha2 inactive mice (AMPKalpha2i), caCaMKKalpha did not increase AMPKalpha1 or -alpha2 activities, but it did increase glucose uptake 2.5-fold, demonstrating that caCaMKKalpha stimulates glucose uptake independent of AMPK. Akt (Thr(308)) phosphorylation was not altered by CaMKKalpha, and caCaMKKalpha plus insulin stimulation did not increase the insulin-induced phosphorylation of Akt (Thr(308)). These results suggest that caCaMKKalpha stimulates glucose uptake via insulin-independent signaling mechanisms. To assess the role of CaMKK in contraction-stimulated glucose uptake, isolated muscles were treated with or without the CaMKK inhibitor STO-609 and then electrically stimulated to contract. Contraction increased glucose uptake 3.5-fold in muscles from both wild-type and AMPKalpha2i mice, but STO-609 significantly decreased glucose uptake (approximately 24%) only in AMPKalpha2i mice. Collectively, these results implicate CaMKKalpha in the regulation of skeletal muscle glucose uptake independent of AMPK and Akt activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287469     DOI: 10.2337/db06-1230

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  Integrating pathway analysis and genetics of gene expression for genome-wide association studies.

Authors:  Hua Zhong; Xia Yang; Lee M Kaplan; Cliona Molony; Eric E Schadt
Journal:  Am J Hum Genet       Date:  2010-03-25       Impact factor: 11.025

Review 2.  AMP-activated protein kinase and its downstream transcriptional pathways.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

3.  Constitutive activation of CaMKKα signaling is sufficient but not necessary for mTORC1 activation and growth in mouse skeletal muscle.

Authors:  Jeremie L A Ferey; Jeffrey J Brault; Cheryl A S Smith; Carol A Witczak
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

Review 4.  Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle.

Authors:  Kristin I Stanford; Laurie J Goodyear
Journal:  Adv Physiol Educ       Date:  2014-12       Impact factor: 2.288

5.  Skeletal Muscle Phospholipid Metabolism Regulates Insulin Sensitivity and Contractile Function.

Authors:  Katsuhiko Funai; Irfan J Lodhi; Larry D Spears; Li Yin; Haowei Song; Samuel Klein; Clay F Semenkovich
Journal:  Diabetes       Date:  2015-10-28       Impact factor: 9.461

6.  p300 Mediates Muscle Wasting in Lewis Lung Carcinoma.

Authors:  Thomas K Sin; James Z Zhu; Guohua Zhang; Yi-Ping Li
Journal:  Cancer Res       Date:  2019-01-31       Impact factor: 12.701

Review 7.  Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise.

Authors:  Katja S C Röckl; Carol A Witczak; Laurie J Goodyear
Journal:  IUBMB Life       Date:  2008-03       Impact factor: 3.885

8.  Exercise training prevents hyperinsulinemia, muscular glycogen loss and muscle atrophy induced by dexamethasone treatment.

Authors:  Matheus Barel; Otávio André Brogin Perez; Vanessa Aparecida Giozzet; Alex Rafacho; José Roberto Bosqueiro; Sandra Lia do Amaral
Journal:  Eur J Appl Physiol       Date:  2009-12-06       Impact factor: 3.078

9.  Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase alpha1 following overload in LKB1 knockout mice.

Authors:  Sean L McGee; Kirsty J Mustard; D Grahame Hardie; Keith Baar
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

Review 10.  Maternal obesity, inflammation, and fetal skeletal muscle development.

Authors:  Min Du; Xu Yan; Jun F Tong; Junxing Zhao; Mei J Zhu
Journal:  Biol Reprod       Date:  2009-06-10       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.